Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Dyne Therapeutics (NASDAQ:DYN) through any online brokerage.
Other companies in Dyne Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Ascentage Pharma Group International (NASDAQ:AAPG), Arcutis Biotherapeutics Inc (NASDAQ:ARQT) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).
Dyne Therapeutics has a consensus price target of $41.65.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $19.42 last updated December 15, 2025 at 2:18 PM EST.
There are no upcoming dividends for Dyne Therapeutics.
Dyne Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Dyne Therapeutics.
Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.